Family Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-105,975
| Closed | -$58K | – | 85 |
|
|
2016
Q3 | $58K | Buy |
105,975
+18,975
| +22% | +$10.4K | 0.03% | 76 |
|
|
2016
Q2 | $51K | Sell |
87,000
-8,000
| -8% | -$4.69K | 0.03% | 79 |
|
|
2016
Q1 | $139K | Buy |
95,000
+5,000
| +6% | +$7.32K | 0.09% | 65 |
|
|
2015
Q4 | $288K | Sell |
90,000
-100,141
| -53% | -$320K | 0.15% | 62 |
|
|
2015
Q3 | $1.19M | Buy |
190,141
+21,070
| +12% | +$132K | 0.52% | 50 |
|
|
2015
Q2 | $1.68M | Buy |
169,071
+86,196
| +104% | +$856K | 0.69% | 43 |
|
|
2015
Q1 | $611K | Buy |
82,875
+16,000
| +24% | +$118K | 0.28% | 53 |
|
|
2014
Q4 | $358K | Buy |
66,875
+1,000
| +2% | +$5.35K | 0.16% | 65 |
|
|
2014
Q3 | $331K | Buy |
65,875
+24,000
| +57% | +$121K | 0.15% | 64 |
|
|
2014
Q2 | $281K | Buy |
41,875
+13,750
| +49% | +$92.3K | 0.14% | 66 |
|
|
2014
Q1 | $204K | Buy |
28,125
+1,545
| +6% | +$11.2K | 0.11% | 68 |
|
|
2013
Q4 | $100K | Buy |
26,580
+14,250
| +116% | +$53.6K | 0.06% | 64 |
|
|
2013
Q3 | $41K | Hold |
12,330
| – | – | 0.03% | 64 |
|
|
2013
Q2 | $41K | Buy |
+12,330
| New | +$41K | 0.02% | 77 |
|